Cover
Jelmyto
Jelmyto 2
Leadership Editorial Staff
Contents
Pfizer
Letter From the President of LUGPA
Bladder and Kidney Cancer Academy
LUGPA News
Cipla
A Comparison of Prostate-Specific Antigen Response in Patients With Metastatic Castration-Sensitive Prostate Cancer Initiated on Apalutamide vs Abiraterone Acetate in Linked Clinical and Claims Databases
2024 Anual Meeting
Real-World Comparison of Deep Prostate- Specific Antigen Response in Patients With Metastatic Castration-Sensitive Prostate Cancer Treated With Apalutamide or Enzalutamide
Management of Adverse Events From Checkpoint Inhibitors in Urologic Practice: Where Are We Today?
PPS Analytics
Integrating JELMYTO (Mitomycin) for Pyelocalyceal Solution Into Community Practice: Practical Tips for the Urologist
LUGPA Ad
Meet the Expert: Lillie Shockney, RN, MAS
Advanced Practice Providers, Urology Workforce Challenges, and Reviews in Urology
Case of the Quarter: Kaposi Sarcoma in a Patient With Testicular Germ Cell Tumor and HIV: A Case Report and Literature Review
Coding Corner: Healthcare Common Procedure Coding System Code G2211, Visit Complexity Inherent to Evaluation and Management
IsoPSA
Bladder & Kidney Cancer Academy
Telix
Telix 2
Pfizer 2